Ardelyx (ARDX) Total Non-Current Liabilities (2013 - 2026)

Ardelyx (ARDX) reported Total Non-Current Liabilities of $330.0 million for Q1 2026, up 38.67% on a YoY basis from $238.0 million in Q1 2025, and up 6.88% quarter-over-quarter from $308.8 million in Q4 2025.

Ardelyx (ARDX) Total Non-Current Liabilities (2013 - 2026) Analysis & Trends

Ardelyx has reported Total Non-Current Liabilities for 14 years, with the latest figure at $330.0 million in Q1 2026.

  • For the quarter ending Q1 2026, Total Non-Current Liabilities rose 38.67% year-over-year to $330.0 million; the trailing twelve-month figure through Mar 2026 stood at $330.0 million (up 38.67% YoY), and the FY2025 full-year result was $308.8 million, up 30.32% from the prior year.
  • Total Non-Current Liabilities for Q1 2026 stood at $330.0 million, up from $308.8 million in the prior quarter.
  • The five-year high for Total Non-Current Liabilities was $330.0 million in Q1 2026, with the low at $67.4 million in Q3 2022.
  • Historically, Total Non-Current Liabilities has averaged $176.5 million across 5 years, with a median of $171.5 million in 2024.
  • Annual changes were most pronounced in 2022 — Total Non-Current Liabilities rose 19.6% — and 2024, when it soared 120.19%.
  • Ardelyx's Total Non-Current Liabilities stood at $80.5 million in 2022, then jumped by 37.4% to $110.6 million in 2023, then soared by 114.26% to $236.9 million in 2024, then soared by 30.32% to $308.8 million in 2025, then climbed by 6.88% to $330.0 million in 2026.
  • The last three Total Non-Current Liabilities figures came in at $330.0 million (Q1 2026), $308.8 million (Q4 2025), and $303.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 42,980.09
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 11.03 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 95.20 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 644,700.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 5.87 Bn
9 Abivax 91.96 Bn 91.96 Bn - 64.76 Mn
10 Ardelyx 1.49 Bn 1.25 Bn 89.66 Mn 330.02 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 330.02 Mn
Dec 31, 2025 308.78 Mn
Sep 30, 2025 303.26 Mn
Jun 30, 2025 299.48 Mn
Mar 31, 2025 238.00 Mn
Dec 31, 2024 236.94 Mn
Sep 30, 2024 185.19 Mn
Jun 30, 2024 173.39 Mn
Mar 31, 2024 169.61 Mn
Dec 31, 2023 110.58 Mn
Sep 30, 2023 84.11 Mn
Jun 30, 2023 87.87 Mn
Mar 31, 2023 79.38 Mn
Dec 31, 2022 80.48 Mn
Sep 30, 2022 67.39 Mn
Jun 30, 2022 68.98 Mn
Dec 31, 2021 67.30 Mn
Dec 31, 2020 74.07 Mn
Sep 30, 2020 65.96 Mn
Jun 30, 2020 69.87 Mn